Search Results - Restelli U

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives by Croce D, Bonfanti M, Restelli U

Connect to this object online.

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review by Silvola S, Restelli U, Bonfanti M, Croce D

Connect to this object online.

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Connect to this object online.

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Connect to this object online.

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies... by Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Connect to this object online.

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis by Monzani R, Barbera G, Restelli U, Galeone C, Petrini F

Connect to this object online.

Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in Italy by Restelli U, Vitale J, Croce E, Bernareggi S, Guida S, Silvola S, Banfi G, Zagra L

Connect to this object online.

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... by Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Connect to this object online.

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? by Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

Connect to this object online.

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service by Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Connect to this object online.

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district by Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

Connect to this object online.